Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.54M | 6.39M | 4.92M | 5.46M | 2.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.54M | 6.39M | 4.92M | 5.46M | 2.83M |
| Cost of Revenue | 1.81M | 1.83M | 1.85M | 2.00M | 1.82M |
| Gross Profit | 1.73M | 4.56M | 3.06M | 3.46M | 1.00M |
| SG&A Expenses | 2.28M | 2.36M | 2.22M | 1.95M | 1.81M |
| Depreciation & Amortization | 56.80K | 99.40K | 94.10K | 117.90K | 117.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.14M | 4.29M | 4.16M | 4.06M | 3.75M |
| Operating Income | -601.00K | 2.10M | 752.00K | 1.40M | -924.80K |
| Income Before Tax | -739.60K | 1.80M | 805.60K | 1.14M | -1.34M |
| Income Tax Expenses | -184.50K | 517.00K | -- | 312.80K | -- |
| Earnings from Continuing Operations | -555.00K | 1.28M | 805.60K | 831.30K | -1.34M |
| Earnings from Discontinued Operations | -1.10K | -8.10K | -- | -11.40K | -1.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.90K | 1.40K | -- | -- | -- |
| Net Income | -548.20K | 1.28M | 805.60K | 819.90K | -1.34M |
| EBIT | -601.00K | 2.10M | 752.00K | 1.40M | -924.80K |
| EBITDA | -544.20K | 2.20M | 846.20K | 1.52M | -807.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 31.40B | 29.93B | 29.75B | 27.58B | 10.57B |
| Average Diluted Shares Outstanding | 31.40B | 482.08B | 509.81B | 27.58B | 10.57B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
